                         SEQUENCE LISTING

<110>  ModernaTX, Inc.

<120>  COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF 
       THERAPEUTIC AGENTS

<130>  MRNA-032/001WO

<150>  US 62/471,937
<151>  2017-03-15

<150>  US 62/475,140
<151>  2017-03-22

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide

<400>  1
caaaggctct tttcagagcc acca                                              24


<210>  2
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide

<400>  3
caaaggcucu uuucagagcc acca                                              24


